KYLYS is proud to receive funding and support from the Office for the Promotion of Industries and Technologies (OPI) to evaluate new features of our technology in collaboration with the University of Geneva!

KYLYS team is grateful for the opportunity to receive valuable training on enterprise competitiveness and innovativeness. Thank you platinn – innovation platform!

Three delegates of KYLYS were present during the BIOTECHGATE DIGITAL PARTNERING If you miss us feel free to contact us via our website or our Linkedin.

We benefit from this useful Entrepreneurship Business Creation program in Biotech.

KYLYS team is excited to present during the BIO-EUROPE SPRING 2021! If you miss us feel free to contact us via or website or our Linkedin

We are proud to announce the latest development of our company, KYLYS. Our patent has been granted in the US for our unique technology: HA Pearls! We are so excited about our upcoming development activities in various applications. We hope you will follow our journey and […]

KYLYS was granted an Innosuisse project to develop HA Pearls product towards novel therapeutic application. This project is in collaboration with the University of Geneva.

KYLYS is pleased to announce that its main patent application filed under the Patent Cooperation Treaty (PCT) convention recently entered the national phases. This is an important step toward protecting KYLYS’s invention in multiple countries worldwide.

We are very proud to have been selected by the BioInnovation Day 2018 organization to present our project HA Pearls. The 8th edition of BioInnovation Day took place on 15 November 2018 at Geneva’s Life Sciences Hub Campus Biotech, providing an opportunity for researchers, scientist-entrepreneurs and […]

Proud to announce that our startup KYLYS won the 2nd prize in the Global Healthcare Innovation Academy (GHIA) in Hong-Kong for its new approach to treat osteoarthritis!